

“We are planning a large population study to see what has happened after people got COVID-19.” “We don’t know when it will emerge,” Shoenfeld said. The challenge is that COVID-19 is still new and autoimmune diseases can sit dormant for months or years there’s no way to know whether the SARSCoV-2 virus will follow a similar path. “There’s another virus, Epstein-Barr virus, responsible for at least 23 autoimmune diseases, and we believe there will be a significant increase in incidence of different autoimmune diseases from COVID-19,” he explained.

1 But, said Yehuda Shoenfeld, MD, “there are several publications that indicate emergence of autoimmune diseases from COVID-19.” Shoenfeld is a professor of medicine at Tel Aviv University’s Zabludowicz Center for Autoimmune Diseases. 1Īccording to researchers, there are “a growing number of case reports of various autoimmune diseases occurring after COVID-19,” but investigators currently lack the large-scale population data required to support the association. One area of particular interest for researchers is that of new-onset autoimmune diseases-the rates of which are currently on the rise, according to a study published in eClinical Medicine. Long COVID, for example, is still not fully understood, and neither are the long-term effects of COVID-19 infection. Nearly 3 years into the global COVID-19 pandemic, there are still some unknowns about the disease.
